Latest debt-to-equity ratio
Cellectar Biosciences Debt-to-equity ratio
Direct answer
Cellectar Biosciences's debt-to-equity ratio is 5.13%.
The verified market snapshot reports 5.13%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 11, 2026.
Get free Cellectar Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 5.13%
Explore related company data
View Cellectar Biosciences's market capitalizationView Cellectar Biosciences's price-to-book ratioView Cellectar Biosciences's return on equityView Cellectar Biosciences's dividend yieldView Cellectar Biosciences's 52-week price rangeView Cellectar Biosciences's profit marginView all Cellectar Biosciences key metricsReturn to Cellectar Biosciences profile